• Award

    ArizonaLEND, Pediatric Pulmonary Center (PPC), and TRANSCEND Nutrition Programs at the Annual Leadership Intensive Workshop

  • DPS

    The Disability Policy Seminar, held in Washington, DC each Spring, provides experiences related to policy development and advocacy on a national level

  • State Capitol

    ArizonaLEND trainees and faculty traveled to the State Capitol in Phoenix to speak with legislators.

The University of Arizona Leadership Education in Neurodevelopmental and Related Disabilities (ArizonaLEND) is a leadership training program that prepares the next generation of policy makers, faculty, clinicians, researchers, family members, and self-advocates to lead the maternal and child health workforce.

News

Jennifer Arenas-Cárdenas, EdS, current ArizonaLEND trainee, was recently featured in a PBS News Hour segment called “Why Mothers with Young Children are Leaving the Workforce.”

The clip highlights three mothers who share personal stories about the pressures and decisions that lead many women to step back from or reconsider their careers.


ArizonaLEND Welcomes Dr. Chelsea Carr as Training Director

The ArizonaLEND program is proud to announce Chelsea Carr, PhD, BCBA-D, as its new training director. Dr. Carr brings a wealth of knowledge and experience to the role and has been a valued member of the ArizonaLEND faculty since 2021. A Board Certified Behavior Analyst, she has extensive expertise supporting families of children with neurodevelopmental disabilities and earned her doctoral degree in Special Education with an emphasis in Applied Behavior Analysis.


Transforming Sleep Apnea Care for people with Down Syndrome: $10.4M Research Grant Awarded

Dr. Daniel Combs, Associate Professor of Pediatrics at the University of Arizona College of Medicine-Tucson and ArizonaLEND alum (2012-2013), and the research team were recently awarded a $10.4 million grant from the Patient-Centered Outcomes Research Institute (PCORI). The grant will be used to evaluate a precision medicine approach to make obstructive sleep apnea (OSA) treatment more effective for people with Down syndrome.